J B Chemicals and Pharmaceuticals share price
You have to be logged in to add this to Watchlist.- ₹1,827.25(0.23%)December 5, 2025 15:29:08 PM IST
- NSE
- BSE
- Vol : 127.74 K (NSE + BSE)Last 20 day avg : 223.09 K
J B Chemicals and Pharmaceuticals is trading 0.23% upper at Rs 1,827.25 as compared to its last closing price. J B Chemicals and Pharmaceuticals has been trading in the price range of 1,838.25 & 1,804.25. J B Chemicals and Pharmaceuticals has given -1.22% in this year & 2.73% in the last 5 days. J B Chemicals and Pharmaceuticals has TTM P/E ratio 37.08 as compared to the sector P/E of 32.51.There are 11 analysts who have initiated coverage on J B Chemicals and Pharmaceuticals. There are 5 analysts who have given it a strong buy rating & 3 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 207.82 Crores in its last quarter.Listed peers of J B Chemicals and Pharmaceuticals include Piramal Pharma (-0.33%), Syngene International (-0.92%), J B Chemicals And Pharmaceutical (0.23%).The Mutual Fund holding in J B Chemicals and Pharmaceuticals was at 19.15% in 30 Sep 2025. The MF holding has increased from the last quarter. The FII holding in J B Chemicals and Pharmaceuticals was at 15.31% in 30 Sep 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Dec 05, 2025, 03:14 PM UTC
- BetaLow volatility0.42Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.01The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.88Annual dividends as a percentage of the stock price.
- P/BLower than historical values8.00The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values38.99Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates overvaluation2.10The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Piramal Pharma | Bearish | 179.95 | -0.33 | 23,919.82 | 177.36 | 3.3 | 0.07 | 40.78 |
| Syngene International | Bearish | 636.50 | -0.92 | 25,759.37 | 54.31 | 5.44 | 0.20 | 8.65 |
| J B Chemicals And Pharmaceutical | Bullish | 1,827.25 | 0.23 | 28,534.38 | 39.45 | 7.43 | 0.75 | 0.19 |
| Eris Lifesciences | Bearish | 1,572.50 | 0.90 | 21,343.41 | 66.44 | 8.2 | 0.43 | 62.42 |
| Alembic Pharmaceuticals | Bearish | 902.00 | -0.02 | 17,694.70 | 34.73 | 3.81 | 1.09 | 0.90 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-11 | Quarterly Results |
| 2025-07-30 | Quarterly Results |
| 2025-05-14 | Audited Results & Final Dividend |
| 2025-02-04 | Quarterly Results & Interim Dividend |
| 2024-11-06 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE572A01036
- BSE Code506943
- NSE CodeJBCHEPHARM
J B Chemicals and Pharmaceuticals is trading at 1827.25 as on Fri Dec 05 2025 09:59:08. This is 0.23% upper as compared to its previous closing price of 1823.10.
The market capitalization of J B Chemicals and Pharmaceuticals is 28534.38 Cr as on Fri Dec 05 2025 09:59:08.
The average broker rating on J B Chemicals and Pharmaceuticals is Buy. The breakup of analyst rating is given below -
- 5 analysts have given a strong buy rating
- 3 analysts have given a buy rating
- 3 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for J B Chemicals and Pharmaceuticals is 1950.30 whereas the 52 wk low is 1303.00
J B Chemicals and Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 37.08
- Sector P/E: 32.51
- Dividend Yield: 0.85%
- D/E ratio: 0.01
J B Chemicals and Pharmaceuticals reported a net profit of 659.58 Cr in 2025.
The Mutual Fund Shareholding was 19.15% at the end of 30 Sep 2025.
EQUITY QUICK LINKS
J B Chemicals and Pharmaceuticals QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.